Indications
Roclanda is indicated for the reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension for whom monotherapy with a prostaglandin or netarsudil provides insufficient IOP reduction.
Composition
- Active substance
- Latanoprost, netarsudil mesilate
- International name (INN)
- latanoprost / netarsudil
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Roclanda
- Active substance
- Latanoprost, netarsudil mesilate
- ATC code
- S01EE
- Group
- Sensory organs
- Therapeutic area
- Glaucoma, Open-Angle, Ocular Hypertension